publication date: Sep. 8, 2017
Issue 33 - Sep. 8, 2017
  • NCI’s Lowy and Schiller win Lasker prize for developing HPV vaccine

    Douglas Lowy and John Schiller have won the 2017 Lasker-DeBakey Clinical Medical Research Award for research that led to development of the human papillomavirus vaccine.
    Lowy, who is completing his stint as the NCI acting director, becomes the first head of the institute—permanent or acting—to win the award, which is described as America’s Nobel Prize.

    The Lasker awards were announced Sept. 6.

  • Conversation with The Cancer Letter

    Lowy: NCI’s intramural program made development of the HPV vaccine possible

    After getting the news that he and collaborator John Schiller have won the 2017 Lasker-DeBakey Clinical Medical Research Award, Douglas Lowy said that part of the credit belongs to the NCI intramural research program.

    Lowy and Schiller got the award for their role in developing the human papillomavirus vaccine, likely preventing millions of deaths worldwide from cervical cancer and HPV-induced malignancies.

  • Another doubling in progress for NIH? Senate appropriators slate $2 billion for NIH in FY18

    The Senate Appropriations Committee Sept. 7 marked up its version of the fiscal 2018 Labor-HHS spending bill, giving NIH an increase of $2 billion over the current year.

    The bill was approved with overwhelming bipartisan support, with a 29-2 vote, and will advance to the White House as soon as the House passes similar legislation. If signed into law, the measure would bring NIH’s budget to $36.1 billion, marking the third year in a row that NIH has received a $2 billion increase.

  • Guest Editorial

    How the RACE for Children Act will get drugs to kids with cancer

    This month, I should be taking my son, Jacob, to college. Instead, I’m participating in Curefest for Childhood Cancer on the Mall here in D.C.

    When Jacob was eight, he was diagnosed with medulloblastoma. The drugs used to treat Jacob were almost 40 years old. They did not work.

  • In Brief

    • H. Richard Alexander named chief surgical officer at Rutgers
    • Weill Cornell awarded $11.3 million SPORE grant for prostate cancer 
    • Fox Chase receives NIH grant to establish a research center in Jamaica
    • NCCN Chemotherapy order templates to be integrated into MEDITECH’s Web EHR
    • ASTRO honors 43 researchers with Abstract Awards at 2017 Annual Meeting
  • Drugs and Targets

    • EC approves Merck’s Keytruda for locally advanced, metastatic urothelial carcinoma
    • FDA grants orphan drug status to Cellect’s ApoGraft for acute and chronic GvHD
  • Funding Opportunities

    • DOD Kidney Cancer Research Program publishes funding opportunities for FY17

Copyright (c) 2017 The Cancer Letter Inc.